Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy

Christophe Depre1, Qian Wang, Lin Yan

  • 1Department of Cell Biology & Molecular Medicine, UMDNJ, Newark, NJ 07103, USA.

Circulation
|October 18, 2006
PubMed

Insights

Chronic pressure overload activates the proteasome system in the heart, which is essential for the development of left ventricular hypertrophy (LVH). This proteasome activation is specific to the subendocardium and required for LVH establishment.

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Proteostasis

Background:

  • Cardiac adaptation to hemodynamic overload depends on protein turnover.
  • Left ventricular hypertrophy (LVH) involves complex molecular adaptations.
  • The role of the proteasome system in LVH development was investigated.

Purpose of the Study:

  • To determine if chronic LVH activates the proteasome system, particularly in the subendocardium.
  • To investigate if the proteasome system is necessary for LVH development.

Main Methods:

  • Assessed proteasome subunit gene and protein expression and activity in canine and mouse models of LVH.
  • Utilized aortic banding to induce chronic LVH.
  • Employed the proteasome inhibitor epoxomicin in a mouse model.

Main Results:

  • Proteasome expression and activity significantly increased in the subendocardium of LVH hearts compared to controls.
  • These changes were specific to the subendocardium and not observed in other cardiac or peripheral tissues.
  • Proteasome inhibition in mice completely prevented LVH development.

Conclusions:

  • Increased proteasome expression and activity in the subendocardium are key features of chronic pressure overload.
  • The proteasome system is a critical requirement for the development of LVH.
Abstract

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
54